Prevalence of breakthrough in chronic hepatitis C patients undergoing antiviral therapy: role of type and schedule of alpha interferon
- 1 February 1997
- journal article
- other
- Published by Elsevier in Journal of Hepatology
- Vol. 26 (2) , 449-450
- https://doi.org/10.1016/s0168-8278(97)80069-4
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Breakthrough during recombinant interferon alfa therapy in patients with chronic hepatitis C virus infection: Prevalence, etiology, and managementHepatology, 1995
- Continuous versus intermittent therapy for chronic hepatitis C with recombinant interferon alfa-2aGastroenterology, 1994
- Treatment of chronic hepatitis C with recombinant human interferon-α2a: Results of a randomized controlled clinical trialHepatology, 1994
- Neutralizing Antibodies to Interferon- : Relative Frequency in Patients Treated with Different Interferon PreparationsThe Journal of Infectious Diseases, 1991